What is Quantificare?
Quantificare stands as a global authority in 2D/3D imaging systems and services, with a specialized focus on clinical trials imaging and aesthetic photography for dermatologists and aesthetic specialists. The company provides standardized imaging solutions, comprehensive project management, and advanced image analysis capabilities, all meticulously tailored for clinical studies. Operating internationally, Quantificare leverages innovative mobile technology and high-quality imaging equipment, such as its LifeViz series, to enhance treatment efficacy and safety through objective and validated imaging systems.
How much funding has Quantificare raised?
Quantificare has raised a total of $4M across 1 funding round:
Other Financing Round
$4M
Other Financing Round (2019): $4M with participation from LBO France
Key Investors in Quantificare
LBO France
LBO France is a prominent investment fund with over three decades of experience in private equity and venture capital, focusing on mid-cap and small-cap investments across France and Europe. The firm is committed to ESG principles and actively invests in innovative sectors, including digital health, aiming to foster sustainable value creation and support the growth of international champions.
What's next for Quantificare?
The recent major strategic investment signals Quantificare's readiness for accelerated scaling and market expansion. With a foundation built on advanced imaging technology for critical healthcare applications, the company is well-positioned to further solidify its leadership in clinical trials and aesthetic dermatology. Future developments are likely to involve enhancing its service offerings, expanding its global reach, and potentially integrating new technological advancements to maintain its competitive edge in the specialized imaging sector.
See full Quantificare company page
